发明名称 |
FGL-2 prothrombinase as a diagnostic tool for malignancy |
摘要 |
The present invention reveals a strong correlation between FGL-2 prothrombinase activity levels and the presence of a malignant proliferative disorder in a subject. Thus, the present invention provides FGL-2 prothrombinase activity as a diagnostic tool for malignancy. |
申请公布号 |
US9023609(B2) |
申请公布日期 |
2015.05.05 |
申请号 |
US201113809697 |
申请日期 |
2011.07.11 |
申请人 |
Mor Research Applications Ltd.;Ramot at Tel-Aviv University Ltd. |
发明人 |
Inbal Aida;Rabizadeh Esther |
分类号 |
C12Q1/37;G01N33/574 |
主分类号 |
C12Q1/37 |
代理机构 |
Marsteller & Associates, P.C. |
代理人 |
Marsteller & Associates, P.C. |
主权项 |
1. A method for the diagnosis of a malignant proliferative disorder in a subject, said method comprising the steps of:
(a) collecting a blood sample from said subject and a blood sample from a normal control; (b) isolating peripheral blood mononuclear cells (PBMC) from said samples; (c) measuring prothrombinase activity in the PBMC from said samples, using a thrombin generation assay, comprising generating thrombin from added prothrombin and determining the thrombin by using a chromogenic substrate; and; (d) comparing the prothrombinase activity of the PBMC from said subject with the prothrombinase activity from said control;whereby a sample with prothrombinase activity higher than control is indicative of the presence of a malignant disorder in said subject. |
地址 |
Tel Aviv IL |